Traws Pharma, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Traws Pharma, Inc. (TRAW) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $6.04 million as of 2015-12-31, per its 10-K filed 2016-03-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2016-03-28
- 2015-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $6.04M.
- 2015-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.15M.
- 2015-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.49M.
- 2014-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $10.45M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2015-12-31 | $6.04M 10-K · filed 2016-03-28 |
| 2015-06-30 | $7.15M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $7.49M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $10.45M 10-K · filed 2015-03-30 |
| 2014-09-30 | $8.02M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $9.87M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $11.04M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $3.60M 10-K · filed 2014-03-20 |
| 2013-09-30 | $3.95M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.35M 10-Q · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |